Research from the University of Virginia School of Medicine suggests how a newly developed gene therapy can treat Dravet syndrome, a severe form of epilepsy, and potentially prolong survival for people with the condition.
Researchers at UCSF have developed a novel, potentially life-saving approach that may prevent antibodies from triggering immune rejection of engineered therapeutic and transplant cells.
Issuing a press statement, Advocate Alok Kumar said, "We are of the clear opinion that no pilgrimage site should be converted into a tourist destination."
The Indian Institute of Technology (IIT) Madras researchers have developed a statistical approach that can characterize subsurface rock structure and detect petroleum and hydrocarbon reserves.
Urging the people not to panic and follow the Covid protocols religiously, Dr Vaibhav Suresh, Specialist Preventive Health, Fortis Hospital on Thursday said Indians were naturally exposed to the virus and have developed herd immunity as a result.
A quarter-sized device developed at Houston Methodist Hospital could significantly alter the course of treatment for Type 1 diabetes, a chronic condition that affects millions of Americans and has no cure.
Researchers have developed a brand-new method for locating and eliminating cancer cells by using synthetic DNA. The procedure was successful in lab tests against cells generated from human cervical cancer, human breast cancer, and mouse malignant melanoma.
A team of neuroscientists led by a University of Pittsburgh School of Medicine researcher developed a blood test to detect a new marker of Alzheimer's disease neurodegeneration.
Bengaluru (Karnataka) [India], December 27 (ANI/BusinessWire India): MIT xPRO has announced two new upskilling programs in Executive Leadership Principles and Machine Learning for Business, Engineering, and Science. Delivered through the digital skills training platform Simplilearn, these pr
PCV15 vaccine was developed by Tergene Biotech and manufactured at Auro Vaccines, which is a wholly-owned subsidiary of Aurobindo Pharma with capabilities in vaccines development and manufacturing. Aurobindo Pharma holds 80 per cent stake in the joint venture company, Tergene Biotech.